Dr Agarwal's Eye

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: INE934C01018
  • NSEID: DRAGARWQ
  • BSEID: 526783
INR
5,072.90
-28.9 (-0.57%)
BSENSE

May 07

BSE+NSE Vol: 563

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
KMC Speciality
Kovai Medical
Yatharth Hospit.
Artemis Medicare
Dr Agarwal's Eye
Jupiter Life Lin
Shalby
Indrapr.Medical
GPT Healthcare
Gujarat Kidney
Unihealth Hosp

Why is Dr Agarwals Eye Hospital Ltd ?

1
Healthy long term growth as Operating profit has grown by an annual rate 83.03%
2
The company has declared Positive results for the last 4 consecutive quarters
  • OPERATING PROFIT TO INTEREST(Q) Highest at 16.93 times
  • PBT LESS OI(Q) At Rs 20.68 cr has Grown at 76.00%
  • PAT(Q) At Rs 17.28 cr has Grown at 66.2%
3
With ROCE of 16.6, it has a Fair valuation with a 4.8 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of NA, its profits have risen by 35.8% ; the PEG ratio of the company is 1.1
4
29.26% of Promoter Shares are Pledged
  • In falling markets, high promoter pledged shares puts additional downward pressure on the stock prices
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Dr Agarwal's Eye should be less than 10%
  2. Overall Portfolio exposure to Hospital should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Hospital)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
28.55%
EBIT Growth (5y)
83.03%
EBIT to Interest (avg)
7.24
Debt to EBITDA (avg)
2.67
Net Debt to Equity (avg)
0.77
Sales to Capital Employed (avg)
0.91
Tax Ratio
23.21%
Dividend Payout Ratio
5.16%
Pledged Shares
29.26%
Institutional Holding
4.33%
ROCE (avg)
15.21%
ROE (avg)
29.83%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
35
Industry P/E
62
Price to Book Value
7.78
EV to EBIT
27.05
EV to EBITDA
18.78
EV to Capital Employed
4.83
EV to Sales
5.97
PEG Ratio
1.09
Dividend Yield
0.13%
ROCE (Latest)
16.58%
ROE (Latest)
22.20%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company
OPERATING PROFIT TO INTEREST(Q)

Highest at 16.93 times

PBT LESS OI(Q)

At Rs 20.68 cr has Grown at 76.00%

PAT(Q)

At Rs 17.28 cr has Grown at 66.2%

DEBT-EQUITY RATIO(HY)

Lowest at 1.07 times

NET SALES(Q)

At Rs 116.22 cr has Grown at 22.20%

-3What is not working for the Company
ROCE(HY)

Lowest at 14.81%

CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 7.89 cr

Loading Valuation Snapshot...

Here's what is working for Dr Agarwal's Eye

Operating Profit to Interest - Quarterly
Highest at 16.93 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 20.68 cr has Grown at 76.00%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 17.28 cr has Grown at 66.2%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
At Rs 116.22 cr has Grown at 22.20%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Debt-Equity Ratio - Half Yearly
Lowest at 1.07 times
in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Dr Agarwal's Eye

Cash and Cash Equivalents - Half Yearly
Lowest at Rs 7.89 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents